Mother-to-child transmission of HIV infection: Nutrition/HIV interactions

Nutrition Reviews

Volumn 58, Issue 2 II, 2000, Pages

  Peckham, Catherine ^a   Newell, Marie Louise ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; ZIDOVUDINE;

BREAST FEEDING; BREAST MILK; CONFERENCE PAPER; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PREGNANCY; VERTICAL TRANSMISSION; VIRUS INFECTION; VIRUS LOAD; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 26444519311     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2000.tb07802.x     Document Type: Conference Paper

References (60)

1. Brockelhurst PFR. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta analysis. Br J Obstet Gynaecol 1998;105:836-48
2. Fawzi WW, Hunter D. Vitamins in HIV disease progression and vertical transmission. Epidemiology 1998;9:457-66
3. Semba RD, Miotti PG, Chiphangwi JD, et al. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 1994;343:1593-7
4. Semba RD. Vitamin A and human immunodeficiency virus infection. Proc Nutr Soc 1997;56:459-69
5. Fawzi WW, Msamanga GI, Spiegelman D, et al. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet 1998;351: 1477-82
6. Taha TE, Dallabetta GA, Canner JK, et al. The effect of human immunodeficiency virus infection on birthweight, and infant and child mortality in urban Malawi. Int J Epidemiol 1995;24:1022-9
7. The Working Group on Mother-to-Child Transmission of HIV. Rates of mother-to-child transmission of HIV-1 in Africa, America and Europe: results from 13 perinatal studies. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:506-10
8. Shaffer N, Roongpisuthipong A, Siriwasin W, et al. Maternal viral load and perinatal human immunodeficiency virus type 1 subytpe E transmission, Thailand. J Infect Dis 1998;179:590-9
9. Tess BH, Rodrigues LC, Newell ML, et al. Sao Paolo collaborative study of vertical transmission of HIV-1: breast-feeding, genetic, obstetric and other risk factors associated with mother-to-child transmission of HIV-1 in Sao Paulo State, Brazil. AIDS 1998; 12:513-20
10. Peckham C, Gibb D. Mother-to-child transmission of the human immunodeficiency virus. N Engl J Med 1995;333:298-302
11. O'Shea S, Newell ML, Dunn D, et al. Maternal viral load, CD4 cell count and vertical transmission of HIV-1. J Med Virol 1998;54:113-7
12. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet 1999;353:773-80
13. European Collaborative Study. Vertical transmission of HIV-1: maternal immune status and obstetric factors. AIDS 1996;10:1675-81
14. Landesman SH, Kalish LA, Burns D, et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. N Engl J Med 1996;334:1617-23
15. John GC, Nduati RW, Mbori-Ngacha D, et al. Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis 1997;175:57-62
16. Mostad SB, Overbaugh J, DeVange DM, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 1997;350:922-7
17. Greenberg BL, Semba RD, Vink PE, et al. Vitamin A deficiency and maternal-infant transmission of HIV in two metropolitan areas in the United States. AIDS 1997;11:325-32
18. Nielsen K, Boyer P, Dillon M, et al. Presence of human immunodeficiency virus (HIV) type 1 and HIV-1-specific antibodies in cervicovaginal secretions of infected mothers and in the gastric aspirates of their infants. J Infect Dis 1996;173:1001-4
19. Ait-Khaled M, Hermione Lyall EG, Stainsby C, et al. Intrapartum mucosal exposure to human immunodeficiency virus type 1 (HIV-1) of infants born to HIV-1-infected mothers correlates with maternal plasma virus burden. J Infect Dis 1998;177:1097-100
20. The International Perinatal HIV Group. Mode of delivery and vertical transmission of HIV-1: a meta-analysis from fifteen prospective cohort studies. N Engl J Med 1999;340:977-87 Abstract
21. The European Mode of Delivery Collaboration. Elective caesarean section versus vaginal delivery in preventing vertical HIV-1 transmission: a randomised clinical trial. Lancet 1999;353:1035-9
22. Newell ML. Mechanisms and timing of mother-to-child transmission of HIV-1. AIDS 1998;12:831-7
23. Dunn D, Brandt CD, Krivine A, et al. The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. AIDS 1995; 9:F7-11
24. Kuhn L, Abrams EL, Matheson PB, et al. Timing of maternal-infant HIV transmission: associations between intrapartum factors and early polymerase chain reaction results. AIDS 1997;11:429-35
25. Chouquet C, Burgard M, Richardson S, et al. Timing of mother-to-child HIV-1 transmission and diagnosis of infection based on polymerase chain reaction in the neonatal period by a non-parametric method. AIDS 1997;11:1183-99
26. Kalish LA, Pitt J, Lew J, et al. Defining the time of fetal or perinatal acquisition of human immunodeficiency virus type I infection on the basis of age at first positive culture. J Infect Dis 1997;175:712-5
27. Dunn D, Newell ML, Ades A, Peckham CS. Risk of human immunodeficiency virus type 1 transmission through breast-feeding. Lancet 1992;340:585-8
28. Ruff AJ, Coberly J, Halsey NA, et al. Prevalence of HIV-1 DNA and p24 antigen in breastmilk and correlation with maternal factors. J AIDS 1994;7:68-73
29. Van de Perre P, Simonon A, Hitimana DG, et al. Infective and anti-infective properties of breastmilk from HIV-1 infected women. Lancet 1993;341:914-8
30. Nduati RW, John GC, Richardson BA, et al. Human immunodeficiency virus type 1-infected cells in breast milk: association with immunosuppression and vitamin A deficiency. J Infect Dis 1995;172: 1461-8
31. Leroy V, Newell ML, Dabis F, et al. International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Lancet 1998;352:597-600
32. Miotti PG, Taha TE, Kumwenda Ml, et al. HIV transmission through breastfeeding. A study in Malawi. JAMA 1999;282:744-9
33. Van de Perre P, Hitimana D, Simonon A, et al. Post-natal transmission of HIV-1 associated with breast abscess. Lancet 1992;339:1490-1
34. Thiry L, Spencer-Goldberger S, Jonckheer T, et al. Isolation of AIDS virus from cell-free breast milk of three healthy virus carriers. Lancet 1985;ii:891-2
35. Vogt MW, Witt DJ, Craven DE. Isolation of HTLV-III/ LAV from cervical secretions of women at risk for AIDS. Lancet 1986;i:525-7
36. Bucens M, Armstrong J, Stuckey M. Virological and electron microscopic evidence for postnatal HIV transmission via breast milk. AIDS 1988;1:339
37. Baba TW, Kock J, Mittler M, et al. Mucosal infection of neonatal rhesus monkeys with cell-free SIV. AIDS Res Hum Retroviruses 1994;10:351-7
38. Featherstone C. M cells: portals to the mucosal immune system. Lancet 1997;350:1230
39. Van de Perre P. Mother-to-child transmission of HIV1: the all mucosal hypothesis as a predominant mechanism of transmission. AIDS 1999;13:1133-8
40. Coutsoudis A, Pillay K, Spooner E, et al. Influence of infant feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa. Lancet 1999;354:471-6
41. Newburg DS, Viscidi RP, Ruff A, Yolken RH. A human milk factor inhibits binding of human immunodeficiency virus to CD4 receptor. Pediatr Res 1992; 31:22-8
42. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-80
43. Saba J. The results of the PETRA intervention trial to prevent perinatal transmission in sub-Saharan Africa. Conference on Retroviruses and Opportunistic Infections. Chicago, 1999
44. Dabis F, Msellati P, Meda N, et al. 6-Month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkina Faso: a double-blind placebo controlled multicentre trial. Lancet 1999;353:786-92
45. Wiktor SZ, Ekpini E, Karon JM, et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: a randomised trial. Lancet 1999;353:781-5
46. The European Collaborative Study. Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one. AIDS 1999;13:1377-85
47. Burman LG, Christensen P, Christensen K, et al. Prevention of excess neonatal morbidity associated with group B streptococci by vaginal chlorhexidine disinfection during labour. Lancet 1992;340:65-9
48. Biggar RJ, Miotti PG, Taha TE, et al. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet 1996;347:1647-50
49. Taha TE, Biggar RJ, Broadhead RL, et al. Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: clinical trial. BMJ 1997;315:216-20
50. Coutsoudis A, Pilay K, Spooner E, et al. Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child transmission of HIV-1 in Durban, South Africa. AIDS 1999;13:1517-24
51. Burger H, Kovacs A, Weiser B, et al. Maternal serum vitamin A levels are not associated with motherto-child transmission of HIV-1 in the United States. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:321-6
52. Nicoll A, Newell ML, Van Praag E, et al. Infant feeding policy and practice in the presence of HIV-1 infection. AIDS 1995;9:107-19
53. Van de Perre P, Simonon A, Msellati P, et al. Postnatal transmission of human immunodeficiency virus type 1 from mother to infant: a prospective cohort study in Kigali, Rwanda. N Engl J Med 1991; 325:593-8
54. Glasziou PP, Mackerras DEM. Vitamin A supplementation in infectious diseases: a meta-analysis. BMJ 1993;306:366-70
55. Semba RD, Miotti P, Chiphangwi JD, et al. Maternal vitamin A deficiency and child growth failure during human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:219-22
56. Coutsoudis A, Bobat RA, Coovadia HM, et al. The effects of vitamin A supplementation on the morbidity of children born to HIV-infected women. Am J Public Health 1995;85:1076-81
57. Fawzi WW, Mbise RL, Hertzmark E, et al. A randomised trial of vitamin A supplements in relation to mortality among human immunodeficiency virus-infected and uninfected children in Tanzania. Paediatr Infect Dis J 1999;18:127-33
58. Hussey G, Hughes J, Potgieter S, et al. Vitamin A status and supplementation and its effects on immunity in children with AIDS. Abstracts of the XVII International Vitamin A Consultative Group Meeting, Guatemala City. Washington, DC: IVACG, 1996;81
59. Read JS, Bethel J, Harris R, et al. Serum vitamin A concentrations in a North American cohort of human immunodeficiency virus type 1-infected children. Pediatr Infect Dis J 1998;18:134-42
60. Graham WJ, Newell ML. Seizing the opportunity: collaborative initiatives to reduce HIV and maternal mortality. Lancet 1999;353:836-9